معرفی
Gang Bao is the Foyt Family Professor of Bioengineering at Rice University, with additional appointments in Chemistry and Materials Science & NanoEngineering. He is a CPRIT Scholar in Cancer Research and leads the Laboratory of Biomolecular Engineering & Nanomedicine. His work focuses on nanomedicine, gene editing (CRISPR/Cas9, TALENs, ZFNs), molecular imaging, and targeted therapies for cancer and genetic disorders like sickle-cell disease. He holds over 180 publications, multiple patents, and founded Vivonetics, Inc. He is a Fellow of the Biomedical Engineering Society, AIMBE, APS, AAAS, and ASME.
Education: Postdoc at UC Santa Barbara (1988-1991), PhD in Applied Mathematics (Lehigh, 1987), M.Sc. (Shandong University, 1981), B.Sc. Mechanical Engineering (Shandong, 1976).
Research interests include genome editing for disease correction (e.g., CRISPR-based therapies), nanotechnology for drug delivery and imaging (superparamagnetic nanoparticles, quantum dots), and cross-disciplinary training in quantitative sciences. His $6M CPRIT grant supports cancer research alongside NIH and NSF funding. Recent work addresses CRISPR off-target effects, CFTR gene correction in cystic fibrosis, and liver-directed gene therapy.
Awards include Georgia Tech’s Outstanding Achievement in Research (2014, 2005), Sigma Xi Best Paper (2005), and plenary lectureships. His lab integrates engineering, biology, and clinical medicine to advance therapies for genetic diseases, leveraging nanoscale tools and biomolecular engineering.
Grants: CPRIT, NIH Common Fund, NHLBI, NSF. Patents: 10 issued or provisional. Collaborations include physician-scientists and clinicians to bridge lab-to-clinic translation. His lab develops tools like TRACE-Seq for tracking edited stem cell dynamics and magnetic nanoparticle systems for targeted delivery.
